R&D

Progresses in relationship between opioid receptor systemand depression and intervention strategies

Source：《Chin J Pharmacol Toxicol》Author：WU Ning , LU Guan-yi Date：2026-06-15

1781505807474279.png

1781505854483245.png1781506086970569.png1781506147241547.png

1781506200348321.png

1781506266632706.png

1781506365387171.png1781506408417112.png1781506538790779.png1781506649660393.png1781506698527241.png1781506880731720.png1781506988386788.png1781507031385722.png1781507088284244.png1781507207169978.png1781507247110469.png1781507374711893.png

1781507557452950.png1781507640197576.png1781507763383618.png1781507850389721.png

1781507911504571.png1781507985117790.png

1781508035524887.png

1781508101393486.png

1781508146113696.png

1781508428592480.png

1781508527151025.png

下载:

阿片受体作用系统与抑郁症发病及干预研究进展_吴宁.pdf

Prev： Preparation and in Vitro and in Vivo Studies of Donepezil Implants

Next： Ｒ Language Assisted Excipient Compatibility and Formulation Optimization of Epirubicin Tablets

Back

You May Like：

Tel：0086 755 84208896

Addr：Changfang Lighting Industrial Factory Building C2-101, Zhukeng Community, Longtian Street, Pingshan District, Shenzhen China

Follow Us


Scan the code to follow Shankang!

Copyright © 2025-2026 Shenzhen Shankang Pharmaceutical Technology Co., Ltd 粤ICP备20040229号-1